268 related articles for article (PubMed ID: 33707479)
1. Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
Han X; Fan J; Li Y; Cao Y; Gu J; Jia X; Wang Y; Shi H
Sci Rep; 2021 Mar; 11(1):5679. PubMed ID: 33707479
[TBL] [Abstract][Full Text] [Related]
2. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
[TBL] [Abstract][Full Text] [Related]
3. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
[TBL] [Abstract][Full Text] [Related]
4. Value of
Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between EGFR, ALK Gene Mutation and Imaging
and Pathological Features in Invasive Lung Adenocarcinoma].
Yang H; Liu Z; Wang H; Chen L; Wang J; Wen W; Xu X; Zhu Q
Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):147-155. PubMed ID: 35340157
[TBL] [Abstract][Full Text] [Related]
6. [Semiquantitative parameters of
Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
[TBL] [Abstract][Full Text] [Related]
7. CT features and disease spread patterns in ROS1-rearranged lung adenocarcinomas: comparison with those of EGFR-mutant or ALK-rearranged lung adenocarcinomas.
Woo JH; Kim TJ; Kim TS; Han J
Sci Rep; 2020 Oct; 10(1):16251. PubMed ID: 33005033
[TBL] [Abstract][Full Text] [Related]
8. Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations.
Wang H; Schabath MB; Liu Y; Han Y; Li Q; Gillies RJ; Ye Z
Eur J Radiol; 2016 Nov; 85(11):1934-1940. PubMed ID: 27776643
[TBL] [Abstract][Full Text] [Related]
9. Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis.
Wang S; Ma P; Ma G; Lv Z; Wu F; Guo M; Li Y; Tan Q; Song S; Zhou E; Geng W; Duan Y; Li Y; Jin Y
Eur J Cancer; 2020 Jan; 124():1-14. PubMed ID: 31707279
[TBL] [Abstract][Full Text] [Related]
10. Clinicoradiological features associated with epidermal growth factor receptor exon 19 and 21 mutation in lung adenocarcinoma.
Zhao FN; Zhao YQ; Han LZ; Xie YS; Liu Y; Ye ZX
Clin Radiol; 2019 Jan; 74(1):80.e7-80.e17. PubMed ID: 30591175
[TBL] [Abstract][Full Text] [Related]
11. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.
Choe J; Lee SM; Kim W; Do KH; Kim S; Choi S; Seo JB
Eur J Radiol; 2021 Jun; 139():109710. PubMed ID: 33862316
[TBL] [Abstract][Full Text] [Related]
12. Imaging-Based Surrogate Markers of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma: A Local Perspective.
AlGharras A; Kovacina B; Tian Z; Alexander JW; Semionov A; van Kempen LC; Sayegh K
Can Assoc Radiol J; 2020 May; 71(2):208-216. PubMed ID: 32062999
[TBL] [Abstract][Full Text] [Related]
13. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
[TBL] [Abstract][Full Text] [Related]
14. Preoperative CT features for prediction of ALK gene rearrangement in lung adenocarcinomas.
Wang H; Wang Y; Zhang H; Han Y; Li Q; Ye Z
Clin Radiol; 2020 Jul; 75(7):562.e21-562.e29. PubMed ID: 32307109
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations.
Zhou JY; Zheng J; Yu ZF; Xiao WB; Zhao J; Sun K; Wang B; Chen X; Jiang LN; Ding W; Zhou JY
Eur Radiol; 2015 May; 25(5):1257-66. PubMed ID: 25577516
[TBL] [Abstract][Full Text] [Related]
16. The prognostic implications of EGFR mutation and ALK rearrangement for the long-term outcomes of patients with resected lung adenocarcinomas.
Kim H; Lee HJ; Hong H; Kim YJ; Kim KG; Jeon YK; Kim YT
Thorac Cancer; 2019 Jul; 10(7):1619-1627. PubMed ID: 31215177
[TBL] [Abstract][Full Text] [Related]
17. CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.
Rizzo S; Petrella F; Buscarino V; De Maria F; Raimondi S; Barberis M; Fumagalli C; Spitaleri G; Rampinelli C; De Marinis F; Spaggiari L; Bellomi M
Eur Radiol; 2016 Jan; 26(1):32-42. PubMed ID: 25956936
[TBL] [Abstract][Full Text] [Related]
18. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
19. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
20. Relationship between epidermal growth factor receptor mutations and CT features in patients with lung adenocarcinoma.
Zhang G; Zhao Z; Cao Y; Zhang J; Li S; Deng L; Zhou J
Clin Radiol; 2021 Jun; 76(6):473.e17-473.e24. PubMed ID: 33731263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]